Popliteal Artery Disease
3
0
0
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
4 treatments under study, led by Drugeluting Balloon Inpact Admiral Medtronic
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 3 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (3)
Prospective Multicenter Study to Confirm the Performance of the Renzan Stent in Treatment of SFA/POP Artery Disease
A Study Comparing the MAGICTouch™ Sirolimus-coated Balloon With a Paclitaxel-coated Balloon for Treating Severe Narrowing or Blockage in the Femoropopliteal Arteries.
Korean Multicenter Prospective Registry of In.PACT DEB for Isolated Popliteal Artery Disease (K-POP Study)
Research Network
Common Treatments
- Drugeluting Balloon Inpact Admiral Medtronic1
- Paclitaxel Drugcoated Balloon Angioplasty1
- Stent Implantation1
- Sirolimus Rapamune Drugcoated Balloon Angioplasty Catheter1
Active Sponsors
- Yonsei University1
- Concept Medical Inc.1
- Terumo Europe N.V.1
Top Investigators
Kishiwada Tokushukai Hospital
Karolinen-Hospital: Klinikum Arnsberg
Beth Israel Deaconess Medical Center
Sengkang General Hospital
Clinique Rhône-Durance
Related Conditions
- Superficial Femoral Artery Disease2